Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer. Nat Commun. 2020 05 29; 11(1):2662.